Patient-Specific Glandular Dose Estimation in Mammography Using Tissue Distribution Models
Researchers developed a framework to estimate the range of normalized glandular dose (DgN) in mammography by accounting for patient-specific glandular tissue distributions derived from single mammographic projections. The study found that glandular tissue depth can cause DgN to vary by up to a factor of three despite identical glandular fraction maps and visually indistinguishable images. This work is important because accurate dose estimation is critical for cancer risk assessment in breast cancer screening, the most common cancer among women.
A new study presents a method for calculating patient-specific ranges of normalized glandular dose (DgN) in mammography by incorporating glandular fraction maps derived from single projections. Using simulated breast tissue distributions and Monte Carlo simulations, researchers tested three configurations—top, center, and bottom placement of glandular tissue—while preserving glandular fraction maps. Results showed that DgN varied substantially (up to threefold) based solely on tissue depth positioning, even when projection images appeared identical. When compared to standard approaches, central glandular placement provided conservative dose estimates (overestimating by less than 5–15% on average), while centroid-based placement underestimated dose by up to 25%. The findings suggest that patient-specific dose bounds can be estimated from limited mammographic information, potentially improving risk assessment in breast cancer screening.
What's missing
The study uses simulated data and does not report validation against actual patient imaging or clinical outcomes. The framework's practical implementation in clinical settings and its impact on screening protocols remain unclear. Additionally, the study does not discuss how this approach would integrate with existing clinical dosimetry workflows or regulatory standards beyond TG-282.
What different sources said
- arXiv physicsCenter
Range of Normalized Glandular Dose for Mammography Using Patient-Specific Glandular Fractions
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.